A

06996

Antengene

4.78

-0.46-8.78%
Closed16:08 08/01 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE5.190/5.240
TODAY RANGE4.720-5.300
VOL10.42M
MARKET CAP3.25B
52 WEEK RANGE0.500-5.920
AVG VOL (3M)5.78M
% TURNOVER1.53%
TURNOVER51.50M
P/E (TTM)-9.421
% RANGE11.07%
EPS(TTM)-0.507
P/E(FORWARD)-10.973
P/B3.535
BVPS1.352
DIVIDEND--
P/S32.717
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.25B
SHARES OUTSTANDING679.45M
NEXT EARNINGS08/21-08/25
FREE FLOAT679.45M
LOT SIZE500
EX-DATE--
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

A

Antengene

06996

-8.78%
4.780

W

Wuxi Apptec

02359

-3.78%
101.700

S

Shanghai Haohai Biological Technology

06826

-1.24%
27.850

H

Hangzhou Tigermed Consulting

03347

-3.32%
53.900

J

JOINN Laboratories (China)

06127

-3.13%
23.200

P

Pharmaron Beijing

03759

-4.18%
21.800

F

Frontage Holdings

01521

+2.04%
1.500

B

BBI Life Sciences

01035

0.00%
3.490

C

China Regenerative Medicine International

08572

--
0.010

C

China Health Group

08225

-1.11%
0.178

M

Mingyuan Medicare Development

00233

0.00%
0.230

V

Viva Biotech Holdings

01873

-4.19%
1.600

M

Mabpharm

02181

-1.82%
0.540

C

China Regenerative Medicine International

08158

-12.50%
0.840

B

BioDlink International

01875

-2.75%
2.480

H

Hua Medicine

02552

-3.02%
3.210

M

MicroPort NeuroScientific

02172

-4.90%
13.600

A

Alphamab Oncology

09966

-5.32%
9.430

S

SinoMab BioScience

03681

-2.50%
3.120

L

Lepu Biopharma

02157

+2.45%
7.950

J

Jacobio Pharmaceuticals Group

01167

-6.18%
7.890
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.